In the present study, we have found that more than 70% of ESCC samples overexpressed ASS1 compared with their adjacent normal tissues, suggesting that these tumors may respond poorly to immunotherapy. The gene discussed is ASS1; the disease is esophageal squamous cell carcinoma.